News Releases

Mar 23, 2021
Biodesix Announces Closing of New $30 Million Term Loan
Increases Company’s Net Liquidity Position and Reduces Near-Term Cash Interest Costs BOULDER, Colo. --(BUSINESS WIRE)--Mar. 23, 2021-- Biodesix, Inc. (NASDAQ: BDSX; “Biodesix” or the “Company”) a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that it
Mar 16, 2021
Biodesix Announces Fourth Quarter and Full Year 2020 Results
Full Year 2020 Revenue Growth of 86% on Record Revenue of approximately $46 million BOULDER, Colo. --(BUSINESS WIRE)--Mar. 16, 2021-- Biodesix, Inc. (NASDAQ: BDSX) a leading data-driven diagnostic solutions company with a focus in lung disease, today announced financial and operating results for
Feb 25, 2021
Biodesix CEO Scott Hutton Selected as One of Top 25 Biotech CEOs of 2021
BOULDER, Colo. --(BUSINESS WIRE)--Feb. 25, 2021-- Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that The Healthcare Technology Report announced Chief Executive Officer, Scott Hutton , as one of the Top 25 Biotech CEOs
Feb 12, 2021
Biodesix to Participate in Two February Conferences
BOULDER, Colo. --(BUSINESS WIRE)--Feb. 12, 2021-- Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that management will participate in two upcoming conferences: the BTIG Virtual MedTech, Digital Health , Life Science &
Displaying 11 - 20 of 23